Scholarlink

Objective <p>This study aimed to assess the impact of combined intra-articular ropivacaine and betamethasone injection on postoperative recovery in patients undergoing arthroscopic rotator cuff repair (ARCR).</p> Methods <p>This retrospective analysis included 80 patients undergoing ARCR. Based on the intervention received, patients were divided into an observation group (n = 40), receiving an intra-articular injection of ropivacaine (100&#xa0;mg) and betamethasone (5&#xa0;mg) post-repair, and a control group (n = 40) undergoing ARCR alone. Outcomes assessed over 12&#xa0;months included pain (visual analogue scale, VAS), shoulder function (SST and Constant scores), range of motion, and complications.</p> Results <p>The observation group reported significantly lower VAS scores than the control group at 3, 6, and 12&#xa0;months postoperatively (P = 0.036, P = 0.042, P = 0.031). At 12&#xa0;weeks, the observation group also showed superior improvement in forward flexion, external rotation, SST scores, and Constant scores (all P &lt; 0.001). The total clinical effective rate was higher in the observation group (92.50% vs. 77.50%, P = 0.004). Regarding safety, no major complications occurred in either group. The incidence of minor complications was comparable between the observation and control groups (10.0% vs. 12.5%, P &gt; 0.05).</p> Conclusion <p>The adjunctive use of intra-articular ropivacaine and betamethasone injection following ARCR provides effective postoperative analgesia and contributes to better early recovery of shoulder function and mobility, offering a valuable enhancement to standard surgical repair.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Comparative clinical study on the results of injecting anything intra-articularly ropivacaine and betamethasone versus arthroscopic rotator cuff repair without injection

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年4月9日

查看全文
  • Yahai Wang,
  • Huachang Cai,
  • Qixian Xiao,
  • Weihong Song,
  • Wenming Dong,
  • Dong Xuan

摘要

Objective

This study aimed to assess the impact of combined intra-articular ropivacaine and betamethasone injection on postoperative recovery in patients undergoing arthroscopic rotator cuff repair (ARCR).

Methods

This retrospective analysis included 80 patients undergoing ARCR. Based on the intervention received, patients were divided into an observation group (n = 40), receiving an intra-articular injection of ropivacaine (100 mg) and betamethasone (5 mg) post-repair, and a control group (n = 40) undergoing ARCR alone. Outcomes assessed over 12 months included pain (visual analogue scale, VAS), shoulder function (SST and Constant scores), range of motion, and complications.

Results

The observation group reported significantly lower VAS scores than the control group at 3, 6, and 12 months postoperatively (P = 0.036, P = 0.042, P = 0.031). At 12 weeks, the observation group also showed superior improvement in forward flexion, external rotation, SST scores, and Constant scores (all P < 0.001). The total clinical effective rate was higher in the observation group (92.50% vs. 77.50%, P = 0.004). Regarding safety, no major complications occurred in either group. The incidence of minor complications was comparable between the observation and control groups (10.0% vs. 12.5%, P > 0.05).

Conclusion

The adjunctive use of intra-articular ropivacaine and betamethasone injection following ARCR provides effective postoperative analgesia and contributes to better early recovery of shoulder function and mobility, offering a valuable enhancement to standard surgical repair.